CERUS CORP

Analysis for Ticker: CERS

Cerus Corp is a company focused on keeping the blood supply safe by using special technology to kill germs in blood. The business is a machine designed to move money from regular people to banks and insiders while the company itself runs out of time. On 01/05/2026, the firm is trapped under 84,8$ million in total debt while its most important source of government cash, a contract with BARDA, is set to expire in 09/2026. The math is a disaster because the grace period on their loans has ended, and they must pay back 24,3$ million in hard cash before the year is over. Even though the stock price is 2,60$, giving the company a 514,0$ million market size, the business is burning through millions of dollars to pay for high-interest loans and free stock for its bosses while its profit margins are collapsing.